Concepedia

Wenqian Kang

WK

Statistics

Publications

4

Citations

258

H-Index

4

Active since

2018

Affiliations

Wuhan University(Current)

Zhongnan Hospital of Wuhan University

Hubei University

Wenqian Kang is an author at Wuhan University specializing in molecular oncology, tumor suppressor genes, and medicine.

ORCID

Publications per year

2018–2022

4

Publications

4

EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation

Liyuan Wang, Chan Chen, Zemin Song et al. · Nature Communications · 2022 · 145 citations · Full text

, , +17

USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression

Rongfu Tu, Wenqian Kang, Mengjie Yang et al. · Oncogene · 2021 · 42 citations

, , +14

USP49 participates in the DNA damage response by forming a positive feedback loop with p53

Rongfu Tu, Wenqian Kang, Xue-fei Yang et al. · Cell Death and Disease · 2018 · 40 citations · Full text

, , +13

c-MYC-USP49-BAG2 axis promotes proliferation and chemoresistance of colorectal cancer cells in vitro

Rongfu Tu, Wenqian Kang, Ye Kang et al. · Biochemical and Biophysical Research Communications · 2022 · 31 citations · Full text

, , +17

1–4 of 4